Edition:
United States

Aeterna Zentaris Inc (AEZS.OQ)

AEZS.OQ on NASDAQ Stock Exchange Capital Market

1.94USD
3:32pm EDT
Change (% chg)

$0.02 (+1.04%)
Prev Close
$1.92
Open
$1.91
Day's High
$1.96
Day's Low
$1.91
Volume
3,706
Avg. Vol
23,135
52-wk High
$3.29
52-wk Low
$1.02

Chart for

About

Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others. The... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $32.13
Shares Outstanding(Mil.): 16.44
Dividend: --
Yield (%): --

Financials

  AEZS.OQ Industry Sector
P/E (TTM): 35.12 214.90 33.15
EPS (TTM): 0.05 -- --
ROI: 6.54 -3.85 13.23
ROE: 20.82 -5.38 15.27

BRIEF-Aeterna Zentaris Reports Qtrly Earnings Per Share $0.87

* AETERNA ZENTARIS REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATING RESULTS

May 07 2018

BRIEF-Aeterna Zentaris Qtrly Loss Per Share $0.03

* AETERNA ZENTARIS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL AND OPERATING RESULTS

Mar 28 2018

BRIEF-Aeterna Zentaris Appoints James Clavijo As CFO

* AETERNA ZENTARIS APPOINTS JAMES CLAVIJO AS CHIEF FINANCIAL OFFICER

Mar 05 2018

BRIEF-Aeterna Zentaris Provides Update On Previously Disclosed Class Action Lawsuit

* AETERNA ZENTARIS PROVIDES UPDATE ON PREVIOUSLY DISCLOSED CLASS ACTION LAWSUIT

Mar 05 2018

Earnings vs. Estimates